Skip to main content
Premium Trial:

Request an Annual Quote

Not Saying No

At Gene Expression, Razib weighs in on the scientists-using-cognitive-enhancing-drugs debate. He's all for it. "Why do scientists take cognitive enhancing drugs? To get the most out of their career, yes, but a byproduct of this is to get the most bang for your buck when it comes to scientific productivity! That is a form of performance enhancement which has consequences for more than personal ego, it may increase the well being of millions (potentially)," he writes.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.